How Investors May Respond To Zymeworks (ZYME) Hiring EcoR1 Executives To Lead R&D And Deals [Yahoo! Finance]
Zymeworks Inc. (ZYME)
Last zymeworks inc. earnings: 3/2 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.zymeworks.com/overview
Company Research
Source: Yahoo! Finance
Scott Platshon as Executive Vice President and Chief Business Officer, both joining full-time from key shareholder EcoR1 Capital to lead R&D and business operations. This move brings deeper oncology drug development and business development expertise directly into the company as it advances its clinical portfolio and manages royalty- and milestone-bearing partnered assets such as Ziihera (zanidatamab-hrii) and pasritamig. We'll now examine how bringing EcoR1 Capital executives in-house to run R&D and business development could influence Zymeworks' investment narrative. AI is about to change healthcare. These 35 stocks are working on everything from early diagnostics to drug discovery . The best part - they are all under $10b in market cap - there's still time to get in early. Zymeworks Investment Narrative Recap To own Zymeworks today, you need to believe its royalty model around partnered assets like Ziihera and pasritamig can eventually support a still early, cash-consumin
Show less
Read more
Impact Snapshot
Event Time:
ZYME
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZYME alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZYME alerts
High impacting Zymeworks Inc. news events
Weekly update
A roundup of the hottest topics
ZYME
News
- Zymeworks to Report First Quarter 2026 Financial Results and Host Conference Call on May 7, 2026 [Yahoo! Finance]Yahoo! Finance
- Zymeworks to Report First Quarter 2026 Financial Results and Host Conference Call on May 7, 2026GlobeNewswire
- Zymeworks Announces Additional Leadership Appointments to Advance Next Phase of Growth [Yahoo! Finance]Yahoo! Finance
- Zymeworks Announces Additional Leadership Appointments to Advance Next Phase of GrowthGlobeNewswire
- Zymeworks appoints Kristin Stafford as CFO [Seeking Alpha]Seeking Alpha
ZYME
Earnings
- 3/2/26 - Miss
ZYME
Sec Filings
- 4/15/26 - Form SCHEDULE
- 4/10/26 - Form 4
- 4/10/26 - Form 4
- ZYME's page on the SEC website